Successful treatment of multidrug resistant Acinetobacter baumannii meningitis.
Successful treatment of multidrug resistant Acinetobacter baumannii meningitis.
复制标题
成功治疗多重耐药鲍曼不动杆菌脑膜炎。
DOI：
--
复制
发表时间：
2007
影响因子：
1.9
通讯作者：
İ. Kaleli
中科院分区：
文献类型：
--
作者：
S. Saçar;H. Turgut;D. H. Cenger;Erdal Coskun;A. Asan;İ. Kaleli
背景
鲍曼不动杆菌是许多医院医院感染的主要原因，而且似乎有迅速产生多重耐药性的倾向。
案例
我们报告两例术后因多药耐药鲍曼不动杆菌而导致的脑膜炎，他们成功地接受了大剂量的美罗培南静脉注射治疗。
结论
多重耐药不动杆菌属。重症监护病房是一个日益令人担忧的问题。大剂量美罗培南用于治疗这些感染。
BACKGROUND
Acinetobacter baumannii is a major cause of nosocomial infections in many hospitals and appears to have a propensity for developing multiple antimicrobial resistance rapidly.
CASES
We report two cases with post-surgical meningitis due to multidrug resistant A. baumannii which were successfully treated with high-dose intravenous meropenem therapy.
CONCLUSIONS
Multidrug resistant Acinetobacter spp. in intensive care units are a growing concern. High-dose meropenem is used in the treatment of these infections.